Opioids and Cancer: Current Understanding and Clinical Considerations

Dhananjay Sah, Hagit Shoffel-Havakuk, Nir Tsur, Megan L. Uhelski, Vijaya Gottumukkala, Juan P. Cata*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Pain is one of the most common symptoms in patients with cancer. Pain not only negatively affects the quality of life of patients with cancer, but it has also been associated with reduced survival. Pain management is therefore a critical component of cancer care. Prescription opioids remain the first-line approach for the management of moderate-to-severe pain associated with cancer. However, there has been increasing interest in understanding whether these analgesics could impact cancer progression. Furthermore, epidemiological data link a possible association between prescription opioid usage and cancer development. Until more robust evidence is available, patients with cancer with moderate-to-severe pain may receive opioids to decrease suffering. However, future studies should be conducted to evaluate the role of opioids and opioid receptors in specific cancers.

Original languageEnglish
Pages (from-to)3086-3098
Number of pages13
JournalCurrent Oncology
Volume31
Issue number6
DOIs
StatePublished - Jun 2024

Keywords

  • cancer
  • cancer biology
  • opioids
  • opioids
  • opioids and cancer biology
  • opioids and immune function

Fingerprint

Dive into the research topics of 'Opioids and Cancer: Current Understanding and Clinical Considerations'. Together they form a unique fingerprint.

Cite this